Cite
APA Citation
Gratch, D., & Zhovtis Ryerson, L. (2022). stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—Commentary. Multiple sclerosis, 28, 695–696. http://access.bl.uk/ark:/81055/vdc_100147158190.0x000033